Search results for " Guidelines"

showing 10 items of 472 documents

ESMO Consensus Conferences: another source of ESMO Clinical Practice Guidelines.

2012

23 SUPPL. 7 vii7 vii10

medicine.medical_specialtyPractice guidelinePractice guidelines as topicConsensus Development Conferences as Topic2720 Hematology610 Medicine & healthCancer researchOrganizational objectivesClinical practiceMedical decision makingHealth care organizationMedicalNeoplasmsMedicineHumansOrganizational ObjectivesMedical physicsSocieties MedicalPriority journalbusiness.industryMedical literatureOrganizational efficiencyProfessional standardConsensus development conferences as topicHematologyConsensus developmentOrganizational developmentClinical PracticeEuropeEditorialOncology10032 Clinic for Oncology and HematologyPractice Guidelines as Topic2730 OncologybusinessInternational cooperationSocietiesHumanAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Modern Strategies in the Prevention of Implant-Associated Infections

2005

The application of medical devices either for temporary or permanent use has become an indispensible part of almost all fields of medicine. However, foreign bodies are associated with a substantial risk of bacterial and fungal infections. Implant-associated infections significantly contribute to the still increasing problem of nosocomial infections. To reduce the incidence of such infections, specific guidelines providing evidence-based recommendations and comprising both technological and nontechnological strategies for prevention have been established. Strict adherence to hygienic rules during insertion or implantation of the device are aspects of particular importance. Besides such basi…

medicine.medical_specialtyProsthesis-Related InfectionsFuture studiesmedicine.drug_class0206 medical engineeringAntibioticsBiomedical EngineeringMedicine (miscellaneous)New materialsBioengineering02 engineering and technologyBiologyProsthesis DesignBacterial AdhesionBiomaterialsCoated Materials BiocompatiblemedicineHumansConnective Tissue ProteinsIntensive care medicineForeign BodiesInfection ControlGeneral Medicine021001 nanoscience & nanotechnologyAntimicrobial020601 biomedical engineeringAnti-Bacterial AgentsSurgeryPractice Guidelines as TopicEquipment Contamination0210 nano-technologyThe International Journal of Artificial Organs
researchProduct

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?

2021

Pharmacogenetics is one of the cornerstones of Personalized Precision Medicine that needs to be implemented in the routine of our patients’ clinical management in order to tailor their therapies as much as possible, with the aim of maximizing efficacy and minimizing toxicity. This is of great importance, especially in pediatric cancer and even more in complex malignancies such as neuroblastoma, where the rates of therapeutic success are still below those of many other types of tumors. The studies are mainly focused on germline genetic variants and in the present review, state of the art is presented: which are the variants that have a level of evidence high enough to be implemented in the c…

medicine.medical_specialtyQH301-705.5Antineoplastic AgentsReviewchemotherapyPediatricsCatalysisInorganic ChemistryNeuroblastomadrug labelQuimioteràpiamedicineHumansMedical physicsBiology (General)Precision MedicinePhysical and Theoretical Chemistryclinical implementation guidelinesQD1-999SNP (single nucleotide polymorphism)Molecular BiologySpectroscopybusiness.industryOrganic ChemistryGenetic variantsGeneral MedicineEvidence-based medicinePrecision medicinePediatric cancerComputer Science ApplicationsChemistryPharmacogeneticsFarmacogenèticabusinessPharmacogenetics
researchProduct

Quality assurance in the treatment of colorectal cancer: the EURECCA initiative

2014

Colorectal cancer is one of the most common cancers in Europe. Over the past few decades, important advances have been made in screening, staging and treatment of colorectal cancer. However, considerable variation between and within European countries remains, which implies that further improvements are possible. The most important remaining question now is: when are we, health care professionals, delivering the best available care to patients with colon or rectal cancer? Currently, quality assurance is a major issue in colorectal cancer care and quality assurance awareness is developing in almost all disciplines involved in the treatment of colorectal cancer patients. Quality assurance has…

medicine.medical_specialtyQuality managementQuality Assurance Health CareColorectal cancercolorectal cancerauditAuditquality assurancemultidisciplinarityFeedbackHealth caremedicineHumansguidelinesIntensive care medicineQuality of Health CareSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAClinical Trials as TopicClinical Auditbusiness.industryCancerHematologyGuidelinemedicine.diseaseSurgeryEuropeClinical trialOncologyData Interpretation StatisticalPractice Guidelines as TopicColorectal NeoplasmsbusinessQuality assurance
researchProduct

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

2020

Genome sequencing and gene-based therapies appear poised to advance the management of rare lipoprotein disorders and associated dyslipidaemias. However, in practice, underdiagnosis and undertreatment of these disorders are common, in large part due to interindividual variability in the genetic causes and phenotypic presentation of these conditions. To address these challenges, the European Atherosclerosis Society formed a task force to provide practical clinical guidance focusing on patients with extreme concentrations (either low or high) of plasma low-density lipoprotein cholesterol, triglycerides, or high-density lipoprotein cholesterol. The task force also recognises the scarcity of qua…

medicine.medical_specialtyRare dyslipidaemiaConsensusSettore MED/09 - Medicina InternaGenotypediagnosisEndocrinology Diabetes and MetabolismMEDLINE030209 endocrinology & metabolism610 Medicine & health03 medical and health sciences0302 clinical medicineEndocrinologyRare DiseasesGenotype540 ChemistryInternal Medicinemedicinegeneome sequencingHumansgeneticsGenetic Predisposition to DiseaseRare dyslipidemias; genetics; diagnosis; treatment030212 general & internal medicineDisease management (health)Intensive care medicineHealth policyDyslipidemias10038 Institute of Clinical Chemistrytreatmentbusiness.industryTask forcegene therapiesDisease ManagementAtherosclerosisPhenotype1310 EndocrinologyEurope2712 Endocrinology Diabetes and MetabolismPhenotype2724 Internal MedicinePractice Guidelines as TopicRare dyslipidemiasEuropean atherosclerosis societylipids (amino acids peptides and proteins)businessQuality information
researchProduct

The use of clinical guidelines for referral of patients with lesions suspicious for oral cancer may ease early diagnosis and improve education of hea…

2010

UNLABELLED Early diagnosis and referral of oral cancer is essential. Successful implementation of clinical guidelines must include current practitioners and students. OBJECTIVE To evaluate the diagnostic accuracy of students at oral cancer screening and to assess the effectiveness of clinical referral guidelines. STUDY DESIGN Fifth year dental students were randomly allocated to either control (n=19) or experimental groups (n = 18). Both received the customary training in oral diagnosis. The experimental group underwent a 2 hour workshop where the guidelines for the referral of suspicious lesions were discussed. Three months later, a set of 51 clinical cases including benign, malignant, and…

medicine.medical_specialtyReferralConcordanceInternal medicineHumansMedicineOral DiagnosisEducation DentalReferral and ConsultationGeneral DentistryEarly Detection of CancerOral cancer screeningHealth professionalsbusiness.industryReproducibility of ResultsCancerGuidelinemedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASPractice Guidelines as TopicOral CancersMouth NeoplasmsSurgerybusiness
researchProduct

Recommendations for the clinical use of somatosensory-evoked potentials

2008

The International Federation of Clinical Neurophysiology (IFCN) is in the process of updating its Recommendations for clinical practice published in 1999. These new recommendations dedicated to somatosensory-evoked potentials (SEPs) update the methodological aspects and general clinical applications of standard SEPs, and introduce new sections dedicated to the anatomical-functional organization of the somatosensory system and to special clinical applications, such as intraoperative monitoring, recordings in the intensive care unit, pain-related evoked potentials, and trigeminal and pudendal SEPs. Standard SEPs have gained an established role in the health system, and the special clinical ap…

medicine.medical_specialtySpinothalamic TractsHealth Planning GuidelinesLaser-Evoked Potentialsintraoperative monitoringMEDLINEcomaElectroencephalographysomatosensory-evoked potentialsClinical neurophysiologyEvoked Potentials SomatosensoryPhysiology (medical)Intensive carelaser-evoked potentialsHumansMedicinepainMedical physicspain-evoked potentialsEvoked potentialcns disease; coma; intensive care; intraoperative monitoring; laser-evoked potentials; pain; pain-evoked potentials; pudendal-evoked potentials; recommendations; somatosensory-evoked potentials; trigeminal-evoked potentialsintensive carecns diseasemedicine.diagnostic_testbusiness.industrytrigeminal-evoked potentialsElectroencephalographyNeurophysiologyElectric StimulationSensory Systemspudendal-evoked potentialsNeurologySomatosensory evoked potentialrecommendationsNeurology (clinical)Nervous System DiseasesbusinessNeuroscienceClinical Neurophysiology
researchProduct

Clinical review: impact of statin substitution policies on patient outcomes.

2009

Background. The increasing awareness of cost issues in health care has led to the increasing use of policy-driven substitution of branded for generic medications, particularly relative to statin treatment for cardiovascular diseases. While there are potential short-term health care savings, the consequences for primary care are under-researched. Our objective was to review data on intensive statin therapy and generic substitution in patients at high cardiovascular risk. Results. Current treatment guidelines for the prevention of cardiovascular disease are consistent in their recommendations regarding statin therapy and treatment targets. Clinical trials demonstrate that to reduce cardiovasc…

medicine.medical_specialtyStatinCost effectivenessmedicine.drug_classDiseasePlaceboReimbursement MechanismsRisk FactorsHealth caremedicineDrugs GenericHumanscardiovascular diseasesIntensive care medicinebusiness.industryPublic healthHealth Policynutritional and metabolic diseasesGeneral MedicineClinical trialEuropeCardiovascular DiseasesPractice Guidelines as TopicPhysical therapyObservational studylipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitorsbusiness
researchProduct

High-Sensitivity C-Reactive Protein and Statin Initiation

2014

The assessment of cardiovascular risk and treatment of cardiovascular diseases are major public health issues worldwide. Inflammation is now recognized as a key regulatory process that links multiple risk factors for atherosclerosis. The substantial number of patients having cardiovascular events lack commonly established risk factors. The utility of high-sensitivity C-reactive protein (hsCRP), a circulating biomarker related to inflammation, may provide additional information in risk prediction. This review will consider the impact of hsCRP level on initiation of statin therapy.

medicine.medical_specialtyStatinmedicine.drug_classInflammationBioinformaticsMultiple risk factorsRisk AssessmentPredictive Value of TestsRisk FactorsmedicineHumanscardiovascular diseasesDyslipidemiasInflammationbiologybusiness.industryPublic healthC-reactive protein3. Good healthCirculating biomarkersC-Reactive ProteinTreatment OutcomeCardiovascular DiseasesPractice Guidelines as TopicPhysical therapybiology.proteinBiomarker (medicine)Statin therapyHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation Mediatorsmedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersAngiology
researchProduct

Organisation of care and initial management of severe head injury in Spain: Results of a national survey

2016

Abstract Objective The main objective of the study is to obtain knowledge about the organisation of care for severe head trauma as well as the initial management of these patients in Neurosurgical Departments in Spain. Material and method A 22-item questionnaire was designed and sent to 59 Neurosurgical Departments. The aim of the questionnaire was to collect data regarding the general profile of the patients with a severe head injury, the general characteristics of the hospitals, the initial care of these patients, the monitoring techniques used, and the measures used to control Intracranial pressure (ICP). Results Of the 59 Neurosurgical Departments identified, 29 (49.2%) completed the qu…

medicine.medical_specialtyTelemedicineSevere head injuryNeurosurgeryIntensive care specialistNeuroimagingComputed tomographyHead trauma03 medical and health sciences0302 clinical medicinemedicineCraniocerebral TraumaHumansIntensive care medicineMonitoring PhysiologicIntracranial pressurePatient Care Teammedicine.diagnostic_testbusiness.industryDisease Management030208 emergency & critical care medicineEmergency departmentmedicine.diseaseTelemedicinehumanitiesSpainBrain InjuriesHealth Care SurveysPractice Guidelines as TopicNeurosurgeryMedical emergencyIntracranial HypertensionEmergency Service HospitalTomography X-Ray ComputedbusinessSurgery Department Hospital030217 neurology & neurosurgeryNeurocirugía (English Edition)
researchProduct